- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 135.38M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $384.7M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $855.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $623.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.07B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.71B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.18B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.71B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.25B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 135.36M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $83.32M |
| Capex | Q1 2025 · Mar 31, 2024 | $28.57M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $52.39M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.92B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $4B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $248.68M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $57.27M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$7.12M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $8M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $241.49M |
| Revenue | Q1 2025 · Mar 31, 2024 | $606.67M |